New Carilion Taubman Cancer Center in Roanoke to Feature MEVION S250i System, Expanding Access to Advanced Cancer Treatment
Carilion Clinic, a leading integrated health system serving western Virginia, and Mevion Medical Systems, the global leader in compact proton therapy, today announced a partnership to bring advanced proton therapy to the new Carilion Taubman Cancer Center, now under construction in Roanoke.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251113737281/en/

A Regional Milestone in Cancer Care
The new Carilion Taubman Cancer Center will transform how cancer care is delivered across Southwest Virginia, bringing together the latest innovations in treatment, research, and clinical education.
When the seven-story facility opens in 2028, it will introduce proton therapy to the region for the first time— positioning Carilion among only three health systems in Virginia to offer this leading-edge treatment. Proton therapy delivers radiation with sub-millimeter precision, minimizing exposure to surrounding healthy tissue and reducing side effects for adult and pediatric patients.
Compact Precision Meets Community Vision
A highlight of the new center will be the MEVION S250i Proton Therapy System™, a single-room solution that makes world-class proton therapy practical and accessible for regional cancer programs. The system’s HYPERSCAN® Pencil Beam Scanning and Adaptive Aperture® multi-leaf collimator delivers the most conformal proton dose available, while its streamlined design minimizes cost, complexity, and treatment time.
“This system allows us to deliver treatment directly to tumors while protecting healthy tissue much more effectively,” said David Buck, MD, Medical Director, Radiation Oncology at Carilion. “It’s a major advancement for patient care, especially in complex cases.”
Together, Carilion and Mevion are advancing a shared mission to make the most precise cancer treatment more accessible to patients and communities across the region.
“Proton therapy represents the next frontier in precision cancer treatment,” said Mike Abbott, President of Carilion Medical Center. “With this technology, our patients will have access to the most advanced cancer treatments close to home—right here in Southwest Virginia.”
“Carilion’s leadership and commitment to expanding cancer care access perfectly align with Mevion’s mission to make proton therapy more compact, affordable, and accessible,” said Tina Yu, Ph.D., CEO and President of Mevion Medical Systems. “Together, we’re ensuring that patients throughout the region benefit from the most advanced radiation treatment technology available.”
About Mevion Medical Systems
Mevion Medical Systems is the leading provider of compact proton therapy systems for cancer care. Dedicated to advancing the design and accessibility of proton therapy worldwide, Mevion pioneered the single-room platform and continues to further the science and application of proton therapy. Since 2013, Mevion compact proton therapy single-room systems have been used by leading cancer centers for treating patients. Mevion’s series of products, including the flagship MEVION S250i and MEVION S250-FIT with HYPERSCAN pencil beam scanning, represent the world’s most compact proton therapy systems that eliminate the obstacles of size, complexity, and cost. Mevion is headquartered in Littleton, Massachusetts with a presence in Europe and Asia. For more information, please visit www.Mevion.com.
About Carilion Clinic
Carilion Clinic is a not-for-profit healthcare organization headquartered in Roanoke, VA. A comprehensive network of hospitals, primary and specialty physician practices and other complementary services provides quality care close to home for nearly 1 million Virginians. With an enduring commitment to the region’s health and wellness, Carilion also advances care through philanthropy, medical education and research, helps the communities it serves stay healthy and inspires the region to grow stronger. For more information, visit CarilionClinic.org.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251113737281/en/
Contacts
Media Contact:
Jacqueline Abner-Pongratz
Jacqueline.Pongratz@mevion.com
